Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
2(33%)
Results Posted
67%(2 trials)

Phase Distribution

Ph not_applicable
1
17%
Ph phase_2
3
50%
Ph phase_4
2
33%

Phase Distribution

0

Early Stage

3

Mid Stage

2

Late Stage

Phase Distribution6 total trials
Phase 2Efficacy & side effects
3(50.0%)
Phase 4Post-market surveillance
2(33.3%)
N/ANon-phased studies
1(16.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

2

trials recruiting

Total Trials

6

all time

Status Distribution
Active(2)
Completed(3)
Terminated(1)

Detailed Status

Completed3
Recruiting2
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
2
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 23 (50.0%)
Phase 42 (33.3%)
N/A1 (16.7%)

Trials by Status

recruiting233%
completed350%
withdrawn117%

Recent Activity

2 active trials
Showing 5 of 6
recruitingphase_4

PCC Treatment for Hemophilia Patients With Inhibitor（2022PCC-A）

NCT07406139
recruitingphase_2

Carboplatin + Paclitaxel + Cetuximab (PCC) After Failure of Pembrolizumab +/- First-line Chemotherapy in Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck

NCT06725368
withdrawnphase_4

PCC and Fibrinogen Compared With FFP in PPH

NCT01910675
completednot_applicable

STI Screening as a Combined HIV Prevention Platform for MSM in Peru

NCT03010020
completedphase_2

An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis Use Among 15 to 17 Year Old Young Men Who Have Sex With Men (YMSM)

NCT01769456
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT07406139Phase 4

PCC Treatment for Hemophilia Patients With Inhibitor（2022PCC-A）

Recruiting
NCT06725368Phase 2

Carboplatin + Paclitaxel + Cetuximab (PCC) After Failure of Pembrolizumab +/- First-line Chemotherapy in Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck

Recruiting
NCT01910675Phase 4

PCC and Fibrinogen Compared With FFP in PPH

Withdrawn
NCT03010020Not Applicable

STI Screening as a Combined HIV Prevention Platform for MSM in Peru

Completed
NCT01769456Phase 2

An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis Use Among 15 to 17 Year Old Young Men Who Have Sex With Men (YMSM)

Completed
NCT01772823Phase 2

An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis

Completed

All 6 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
6